ArticleFrontiers in immunology2026
Melatonin is associated with cell-type-specific inflammatory and oxidative stress responses at the maternal-fetal interface.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Melatonin regulates inflammation and oxidative stress at the placenta, but its effects on specific placental cell types remain unclear. This study investigated how melatonin influences inflammatory and oxidative stress responses, cytokine secretion, NRF2-associated antioxidant responses, and transcriptomic responses in JEG-3 trophoblast-like cells and primary decidual macrophages exposed to lipopolysaccharide (LPS). Melatonin reduced LPS-induced inflammatory cytokine production and intracellular reactive oxygen species accumulation, with pretreatment producing the strongest anti-inflammatory effects. Although NLRP3 transcript expression differed according to treatment sequence, melatonin was associated with reduced inflammatory cytokine secretion despite limited changes in total NLRP3 protein expression. Melatonin also differentially influenced antioxidant responses across placental cell types, with decidual macrophages exhibiting broader functional and transcriptional changes than JEG-3 trophoblast-like cells. Transcriptomic profiling revealed dose- and cell type-dependent effects, with decidual macrophages exhibiting altered expression of genes and pathways associated with inflammatory signaling, oxidative phosphorylation, and reactive oxygen species regulation. In contrast, JEG-3 trophoblast-like cells demonstrated limited transcriptional remodeling and more modest engagement of inflammatory signaling pathways than primary decidual macrophages. These findings suggest that melatonin differentially modulates inflammatory and oxidative stress responses across placental cell types at the maternal-fetal interface. Collectively, these data support the potential role of melatonin in promoting placental redox-inflammatory balance during inflammatory stress and provide a foundation for future studies in physiologically relevant models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.